Prolonged Complete Response With Combined Dabrafenib and Trametinib After BRAF Inhibitor Failure in BRAF-Mutant Glioblastoma

Journal article

Open access

Peer reviewed

JCO precision oncology, Vol.4(4), pp.44-50

2020-02-03

PMID: 32923904

Abstract

Case Reports

url

https://doi.org/10.1200/PO.19.00272View

Published (Version of record) Open

5 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.113 Brain Imaging; 1.113.453 Glioblastoma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Prolonged Complete Response With Combined Dabrafenib and Trametinib After BRAF Inhibitor Failure in BRAF-Mutant Glioblastoma
Creators: Marina Kushnirsky - Department of Neurology, University of Miami, Miami, FL
Lynn G Feun - Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
Sakir H Gultekin - Department of Pathology, University of Miami, Miami, FL
Macarena I de la Fuente - Department of Neurology, University of Miami, Miami, FL
Publication Details: JCO precision oncology, Vol.4(4), pp.44-50
Publisher: American Society of Clinical Oncology
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Department of Pathology; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Neurology - Neuro-Oncology Div
Language: English
Resource Type: Journal article
PMID: 32923904
Record Identifier: 991031576325902976